Aspirin may decrease threat of aggressive type of ovarian cancer New research demonstrates women who regularly use pain relief medications, particularly aspirin, have a reduced risk of serous ovarian cancer – an intense carcinoma affecting the top of ovary. The study released in Acta Obstetricia et Gynecologica Scandinavica reports that nonaspirin non-steroidal anti-inflammatory medications , paracetamol , or other analgesics didn’t decrease ovarian cancers risk viagra ou levitra . Ovarian cancer may be the deadliest gynecological malignancy and the fifth-leading cause of death by cancer for women in developed countries. Prior studies survey that Denmark has one of the highest incidence and mortality rates at 11 and 7 per 100,000 women, respectively.
Ashoka and Boehringer Ingelheim initiative to promote health The social entrepreneurial organization Ashoka and pharmaceutical company Boehringer Ingelheim on Tuesday announced they are launching a three-year global initiative targeted at promot[ing] healthy individuals, communities and families by identifying and supporting the most promising solutions to challenging health problems, according to an Ashoka press release. The Making More Wellness initiative will consist of[e] support for a series of programs targeted at identifying innovative health solutions . This content was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation.